title: Complications of anticoagulation.
authors: Ozlem
authors: O
authors: Bilen
authors: Jun
authors: J
authors: Teruya
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects; D000069604:Dabigatran; D004340:Drug Contamination; D016903:Drug Monitoring / Q000379:methods*; D018565:Food-Drug Interactions; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000517:prevention & control; D007279:Injections, Subcutaneous / Q000009:adverse effects; D009336:Necrosis / Q000209:etiology / Q000517:prevention & control; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control; D012871:Skin Diseases / Q000139:chemically induced / Q000517:prevention & control; D040521:Subcutaneous Tissue / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D006493:Heparin; D000069604:Dabigatran